Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Anchiano Therapeutics Ltd.
Cambridge, Massachusetts, USAbiocancell.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Anchiano Therapeutics was a clinical-stage biopharmaceutical company focused on developing novel therapies—primarily a first-in-class gene therapy—for non-muscle invasive bladder cancer. Its lead candidate, inodiftagene vixteplasmid, showed promising complete response rates in early trials and advanced into registrational studies. The company also developed small molecule programs targeting the RAS and β-catenin pathways. In March 2021, Anchiano merged with Chemomab Ltd., after which its independent development activities ceased and some assets were divested or discontinued.[8][9]
- Therapeutic areas
- OncologyImmunology
- Modalities
- Gene therapy[6]Small molecules[5]Monoclonal antibodies (limited pipeline evidence)[4]
- Industry
- Biotech
02
Partnerships
Collaboration/license agreement with ADT Pharmaceuticals LLC for pan-RAS and PDE10/β-catenin programs [5].
Beyond the preview
Go deeper on Anchiano Therapeutics Ltd..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Anchiano Therapeutics Ltd..